Online and in the news: Cancer trials, fatty foods and carrying shopping as excercise

CANCER TRIALS: A life-extending combination of two drugs has been hailed a “monumental step forward” in the treatment of one of the most deadly cancers.

Pairing the chemotherapy drugs gemcitabine and capecitabine dramatically increases the chances of people with pancreatic cancer living at least five years, trial results have shown.

The treatment protocol should now become the new standard of care for patients who have had surgery, experts say.